MedinCell S.A.
MEDCL.PA · PAR
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€18,438 | -€25,038 | -€32,010 | -€24,806 |
| Dep. & Amort. | €1,990 | €1,719 | €1,665 | €1,516 |
| Deferred Tax | €0 | €0 | €1,000 | €83 |
| Stock-Based Comp. | €2,962 | €2,809 | €2,279 | €2,394 |
| Change in WC | €24,534 | €3,178 | -€3,036 | -€2,367 |
| Other Non-Cash | €8,417 | €5,410 | €9,097 | €1,818 |
| Operating Cash Flow | €19,465 | -€11,922 | -€21,005 | -€21,362 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€747 | -€324 | -€1,027 | -€1,974 |
| Net Acquisitions | €0 | €0 | €48 | €16 |
| Inv. Purchases | €0 | €0 | -€326 | -€1,212 |
| Inv. Sales/Matur. | €0 | €0 | €2,559 | €1,547 |
| Other Inv. Act. | -€12,463 | -€289 | €44 | €1,307 |
| Investing Cash Flow | -€13,210 | -€613 | €1,298 | -€316 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€4,107 | €5,076 | €5,828 | €470 |
| Stock Issued | €39,837 | €23,321 | €810 | €48 |
| Stock Repurch. | €0 | -€25 | €0 | -€192 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | -€2,406 | -€2,844 | -€5,082 | -€1,126 |
| Financing Cash Flow | €33,324 | €25,528 | €1,556 | -€800 |
| Forex Effect | €0 | €0 | €1 | €0 |
| Net Chg. in Cash | €39,580 | €12,993 | -€18,150 | -€22,478 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €19,460 | €6,467 | €24,617 | €47,095 |
| End Cash | €59,040 | €19,460 | €6,467 | €24,617 |
| Free Cash Flow | €17,805 | -€13,113 | -€22,032 | -€23,336 |